Skip to main content

Table 5 Productivity losses due to excess deaths attributable to resistant infection (Indirect Cost)

From: Enumerating the economic cost of antimicrobial resistance per antibiotic consumed to inform the evaluation of interventions affecting their use

 

Thailand

United States

S. aureus

E. coli

K. pneumoniae

A. baumanii

P. aeruginosa

S. aureus

E. coli

K. pneumoniae

A. baumanii

P. aeruginosa

Excess deaths

2799

597

288

15,168

270

11,285

690

1620

500

440

GDP/capita (US$)a

5907

57,466

Indirect Cost (million US$)

150.5

32.1

15.5

815.3

14.5

5901.4

360.8

847.2

261.5

230.1

RMf

0.37

0.27

0.35

0.45

0.52

0.37

0.27

0.35

0.45

0.52

Indirect cost due to human consumption (million US$)

55.7

8.7

5.4

366.9

7.6

2183.5

97.4

296.5

117.7

119.7

  1. a Data from World Bank